(1)
Lacey, J.; Hewitt, J.; Daley-Morris, J. L.; James, J.; Stevens, J.; Blaizel, O. Expert Clinical Framework Report: Management of Adverse Events Related to Novel Therapies for relapsed/Refractory Multiple Myeloma (RRMM). Can Hematol Today 2022, 1.